Savills has announced the acquisition of American company T3 Advisors as part of its strategic expansion into the American market. The company’s new acquisition is a consultant specialised in real estate solutions and workspaces for pharmaceutical and technological companies seeking strategic advice on all aspects of real estate decision taking.
T3 Advisors, founded in 2001 and with offices in Boston, New York, San Francisco and Palo Alto, has focused its business in applying an integrated approach, which includes both the strategy and the execution when it comes to providing clients with office real estate solutions and strategic advisement, assessment and trading services.
The company has become a reference in innovative real estate advisement for CEOs betting on change within a very dynamic entrepreneurial context. Through its studios, T3 Advisors provides opportunities for entrepreneurs to connect with the appropriate resources. Savills’ platform and its international reach will allow T3 Advisors to accelerate its growth both in the United States and the United Kingdom, and in Europe and the Asia-Pacific region.
«The acquisition of T3 will expand even more our pharmaceutical and technological advisory services for our global clients», stated Mark Ridley, global managing director at Savills.
